V
Viet Nam Medicinal Materials JSC
VN:DVM
Viet Nam Medicinal Materials JSC
VN:DVM
Price:
8 400
VND
-1.18%
Market Closed
Market Cap:
₫395.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
0.5
Current
10%
Cheaper
vs 3-y average of 0.6
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
EV/S
=
0.5
Enterprise Value
/
₫694.6B
Revenue
₫1.5T
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
EV/S
=
0.5
Enterprise Value
/
₫694.6B
Revenue
₫1.5T
Valuation Scenarios
Viet Nam Medicinal Materials JSC is trading
below
its 3-year average
If EV/S returns to its 3-Year Average (0.6), the stock would be worth ₫9 300.78 (11% upside from current price).
Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+413%
Average Upside
170%
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | ₫8 400 |
0%
|
| 3-Year Average | 0.6 | ₫9 300.78 |
+11%
|
| 5-Year Average | 0.6 | ₫9 300.78 |
+11%
|
| Industry Average | 2.8 | ₫43 088.81 |
+413%
|
| Country Average | 1.9 | ₫28 958.89 |
+245%
|
Forward EV/S
Today’s price vs future revenue
Not enough data available to calculate forward EV/S
Peer Comparison
All Countries
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| VN |
V
|
Viet Nam Medicinal Materials JSC
VN:DVM
|
395.3B VND | 0.5 | 9.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
835.2B USD | 13.3 | 40.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.8B USD | 6 | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 5.2 | 28 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223.1B CHF | 5.2 | 19.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
276.9B USD | 4.8 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 108.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 4.1 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.5B USD | 3.2 | 19.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.2B USD | 3.1 | 16.8 |
EV/S Multiple
P/E Multiple
Market Distribution
Lower than 84% of
companies
in
Vietnam
Percentile
16th
Based on 187 companies
V
16th percentile
0.5
Low
0 — 0.9
Typical Range
0.9 — 4.6
High
4.6
—
∞
Distribution Statistics
Vietnam
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.9 |
| 70th Percentile | 4.6 |
| Max | 266.8 |
Other Multiples
Viet Nam Medicinal Materials JSC
Glance View
The company is headquartered in Phu Tho, Phu Tho. The company went IPO on 2022-07-19.
DVM
Intrinsic Value
19 840.81
VND
Undervaluation 58%
V
